NEW YORK — Advanced Biological Laboratories said on Tuesday that it has received CE-IVD marking for its DeepChek sequencing-based assays for HIV genotyping and drug resistance testing.
According to Luxembourg-based ABL, the DeepChek-HIV assays cover the protease/reverse transcriptase and the integrase regions of the virus, respectively, and are intended for use with input RNA extracted from plasma, serum, or whole blood samples.